ClinicalTrials.Veeva

Menu

Intravenous Terbutaline to Facilitate Labor Epidural Catheter Placement

K

Kai Schoenhage

Status and phase

Unknown
Phase 4

Conditions

Labor Pain

Treatments

Drug: Fentanyl
Drug: 0.9% NaCl
Drug: Terbutaline

Study type

Interventional

Funder types

Other

Identifiers

NCT01651962
12-0412

Details and patient eligibility

About

Labor pain is a major factor in making the placement of an epidural catheter difficult. The epidural, once in place and dosed, eventually decreases the parturient's pain. To achieve this goal as fast and safely as possible it would be helpful to have a parturient who can tolerate and co-operate with the placement of the epidural catheter.

Briefly stopping contractions, the cause of labor pain, could be the key to achieve this goal.

This study will evaluate the safety, efficacy and duration of the drug terbutaline for this purpose.

Enrollment

250 estimated patients

Sex

Female

Ages

18 to 53 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • in labor
  • labor pain >3 on visual analog scale (VAS)

Exclusion criteria

  • cardiovascular disease
  • preeclampsia
  • diabetes mel-litus
  • thyroid disease
  • current (outpatient) opioid medication
  • recent and / or current use of cocaine
  • seizure disorder
  • psychiatric disease
  • body mass index >35
  • preterm labor (<37 weeks pregnant)
  • known allergies to any of the three study substances

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

250 participants in 3 patient groups, including a placebo group

Terbutaline
Experimental group
Description:
Terbutaline 0.125mg i.v. x 1 dose prior to positioning for epidural placement; may repeat x1 PRN
Treatment:
Drug: Terbutaline
Fentanyl
Active Comparator group
Description:
Fentanyl 100mcg i.v. x 1 dose prior to positioning for epidural placement; may repeat x1 PRN
Treatment:
Drug: Fentanyl
Placebo
Placebo Comparator group
Description:
0.9% NaCl i.v. x 1 dose prior to positioning for epidural placement; may repeat x1 PRN
Treatment:
Drug: 0.9% NaCl

Trial contacts and locations

2

Loading...

Central trial contact

Kai Schoenhage, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems